Succinic Acid

Succinic Acid

SCHEMBL80940

CCO.O=C(O)CCC(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.69
EGLN1 Q9GZT9 2/20 0.69
ALKBH5 Q6P6C2 1/20 0.69
SUCNR1 Q9BXA5 1/20 0.69
FFAR3 O14843 2/20 0.62
HDAC3 O15379 1/20 0.62
HDAC1 Q13547 1/20 0.62
HDAC2 Q92769 1/20 0.62
HDAC8 Q9BY41 1/20 0.62
SLC15A2 Q16348 1/20 0.59
AKR1B1 P15121 1/20 0.53
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 6/20 0.50
PPARD Q03181 6/20 0.50
PPARA Q07869 6/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 4/20 0.50
ALDH1A1 P00352 2/20 0.50
SLC22A6 Q4U2R8 2/20 0.50
TLR2 O60603 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL28778353 0.96 LMNA (0.64) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL28106104 0.96 LMNA (0.64) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL6330595 0.96 LMNA (0.64) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL28754734 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL9391851 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL2305655 0.93 LMNA (0.61) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL28184121 0.88 LMNA (0.75) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL15323174 0.87 LMNA (0.53) LMNAEGLN1ALKBH5SUCNR1FFAR3
Succinic Acid SCHEMBL28454927 0.87 LMNA (0.55) LMNAEGLN1ALKBH5SUCNR1FFAR3
Levulinic Acid SCHEMBL27736725 0.87 LMNA (0.82) LMNAEGLN1ALKBH5SUCNR1FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4157348-A1 COMPOSITIONS AND METHODS FOR TREATING MORPHINE, HEROIN, AND ALCOHOL DEPENDENCE Behnam, Babak (US) 2023-04-05 EP claimed
CN-114588272-A NO-loaded docetaxel nano-drug and preparation method and application thereof 皖西学院 2022-06-07 CN claimed
CN-107382728-A 2 (3,4 dihydroxy phenyl) ethanol succinates and its extracting method and application 大理大学 2017-11-24 CN claimed
CN-105244165-A Chip type high-voltage aluminum electrolytic capacitor, electrolyte thereof and preparation method of electrolyte FENGHUA ADVANCED TECHNOLOGY HOLDING CO LTD 2016-01-13 CN claimed
US-20150133577-A1 VINYL ACETATE-ETHYLENE COPOLYMER EMULSION AND PAPER COATING COMPOSITION BASED ON THE SAME CELANESE INTERNATIONAL CORPORATION (US) 2015-05-14 US claimed
EP-2850141-A1 VINYL ACETATE-ETHYLENE COPOLYMER EMULSION AND PAPER COATING COMPOSITION BASED ON THE SAME Celanese International Corporation (US) 2015-03-25 EP claimed
CN-103694238-A NO donor type matrine derivative and preparation method and medical application thereof HE LIQIN 2014-04-02 CN claimed
WO-2013170411-A1 VINYL ACETATE-ETHYLENE COPOLYMER EMULSION AND PAPER COATING COMPOSITION BASED ON THE SAME CELANESE INTERNATIONAL CORPORATION (US) 2013-11-21 WO claimed
WO-2013113152-A1 VINYL ACETATE-ETHYLENE COPOLYMER EMULSION AND POLYMER CEMENT WATERPROOF COMPOSITION BASED ON THE SAME CELANESE INTERNATIONAL CORPORATION (US) 2013-08-08 WO claimed
CN-116891458-A Preparation method of ilaprazole 南京唯创远医药科技有限公司 2023-10-17 CN disclosed
CN-116356562-A Low-oil consumption polyester FDY spinning oil for WINGS equipment and preparation method thereof 浙江恒逸石化研究院有限公司 2023-06-30 CN disclosed
US-20230190904-A1 Compositions and Methods for Treating Morphine, Heroin, and Alcohol Dependence Behnam, Babak (US) 2023-06-22 US disclosed
EP-4157348-A1 COMPOSITIONS AND METHODS FOR TREATING MORPHINE, HEROIN, AND ALCOHOL DEPENDENCE Behnam, Babak (US) 2023-04-05 EP disclosed
US-11572564-B2 Microorganisms for producing 1,4-butanediol and methods related thereto GENOMATICA, INC. (US) 2023-02-07 US disclosed
WO-2003095665-A2 PMEA AND PMPA CYCLIC PRODUCING SYNTHESIS METABASIS THERAPEUTICS, INC. (US) 2003-11-20 WO disclosed
US-20030162832-A1 L-DOPA ethyl ester salts and uses thereof TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2003-08-28 US disclosed
WO-2003041646-A2 L-DOPA ETHYL ESTER SALTS AND USES THEREOF TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2003-05-22 WO disclosed
CN-1395923-A Application of xanthiphenylketamine or its salt in preparing medicines to treat cardiovascalar disease ZHONGWEI BIOTECHNOLOGY CO LTD (CN) 2003-02-12 CN disclosed
WO-2002069949-A2 COMBINATION THERAPY FOR REDUCTION OF TOXYCITY OF CHEMOTHERAPEUTIC AGENTS PRENDERGAST PATRICK T (IE) 2002-09-12 WO disclosed
CN-1365273-A Percutaneous administration preparations KAO CORP (JP) 2002-08-21 CN disclosed